Storys aus San Francisco

Filtern
  • 30.07.2018 – 15:59

    DX.Exchange

    NFX Invests in Crypto Exchange DX.Exchange

    Tallinn, Estonia (ots/PRNewswire) - Silicon Valley-based NFX partners with DX.Exchange to build the world's leading regulated crypto exchange DX. Exchange just announced they've received investment from notable Silicon Valley VC firm NFX (http://www.nfx.com ) to build the world's leading regulated crypto exchange. DX.Exchange, the newest member of NFX, has attracted remarkable attention due to their free trading business ...

  • 12.07.2018 – 08:01

    Oura Health Ltd.

    Oura Health Strengthens Its Position in the US Market

    Oulu, Finland (ots/PRNewswire) - Company moves to 12.5MEUR in total private funding and appoints new board members with US industry expertise for latest growth phase Oura Health (https://ouraring.com/), the Finnish health technology company behind the Oura ring, has moved its total private funding to 12.5MEUR after the closure of a round led by US-based Bold Capital Partners (http://www.boldcapitalpartners.com/) and ...

  • 07.06.2017 – 19:01

    Deep Instinct

    Lane Bess Appointed to be Executive Chairman of Deep Instinct

    San Francisco (ots/PRNewswire) - Today, Deep Instinct (http://www.deepinstinct.com), the first company to apply deep learning to cybersecurity, is pleased to announce the appointment of Lane Bess to the new role of Executive Chairman of the Board. Lane's background will lend extensive operational guidance. Having led in key roles as CEO and President of Palo Alto ...

  • 06.09.2016 – 08:02

    P.I.Works

    Turkcell Group Selects P.I. Works' uSON(TM) Solution for Superior Subscriber Experience

    Istanbul, San Francisco and Singapore (ots/PRNewswire) - Turkcell, an integrated communication and technology services provider which serves about 66.5 million customers in Turkey and its region, selects to deploy P.I. Works' uSON TM (unified Self-Organizing-Networks) solution. uSONTM automates management and optimization of complex mobile networks 24/7 to improve ...

  • 18.11.2015 – 23:06

    Alios BioPharma, Inc., part of the Janssen Pharmaceutical Companies

    New Data Published in the New England Journal of Medicine Shows Potential of Compound to Fight RSV Infection in Adults and Children

    San Francisco (ots/PRNewswire) - - ALS-008176 now being evaluated in RSV-infected infants - Alios BioPharma, Inc., part of the Janssen Pharmaceutical Companies announced that the New England Journal of Medicine (NEJM) will publish findings from a respiratory syncytial virus (RSV) challenge study for ALS-008176, a ...